The three preferred antiviral mechanisms that MSCs might exhibit in the context of a respiratory viral infection, such as COVID-19, include increased surface expressions of MSCs specific IFN-stimulated genes, secondary response to IFN, leading to the induction of MSC-stimulated genes that contribute to widespread viral resistance, and third modulation of the immune system. Here, IFNA1 is linked to COVID-19.